Stockholm - Delayed Quote SEK
CombiGene AB (publ) (COMBI.ST)
2.4300
+0.0200
+(0.83%)
At close: 1:09:36 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-29,949
-29,949
-30,557
-16,665.6830
22,114.8170
Investing Cash Flow
-81
-81
-994
--
-147.7320
Financing Cash Flow
--
--
--
--
65,881.4640
End Cash Position
73,748
73,748
101,440
131,777.4550
136,743.7930
Capital Expenditure
--
--
-108.9000
--
-147.7320
Issuance of Capital Stock
--
--
--
--
65,881.4640
Free Cash Flow
-29,949
-29,949
-30,557
-16,665.6830
21,967.0850
12/31/2021 - 5/25/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLYM Climb Bio, Inc.
1.2800
-4.48%
CEROW CERo Therapeutics Holdings, Inc.
0.0121
+21.00%
TENX Tenax Therapeutics, Inc.
5.56
+1.74%
UBX Unity Biotechnology, Inc.
0.9801
-0.60%
AVIR Atea Pharmaceuticals, Inc.
2.8250
-0.88%
SAGE Sage Therapeutics, Inc.
7.60
-0.26%
SCPX Scorpius Holdings, Inc.
0.0680
-48.48%
KZIA Kazia Therapeutics Limited
3.2400
-1.82%
TIL Instil Bio, Inc.
19.47
-5.12%
SWTX SpringWorks Therapeutics, Inc.
41.78
+1.37%